The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery (RECOVER)

October 27, 2021 updated by: Radboud University Medical Center

RECOVER Study: the Effect of Low- Versus Normal Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on the Early Quality of Recovery With Perioperative Care According to the Enhanced Recovery Principles

Randomised controlled trial comparing the effect of low pressure pneumoperitoneum with deep neuromuscular block versus normal pressure pneumoperitoneum with moderate neuromuscular block during laparoscopic colorectal surgery on early quality of recovery.

Study Overview

Detailed Description

Rationale: the laparoscopic approach reduced trauma as compared to open surgery, however, the pressure used to create a PNP with sufficient surgical workspace still leads to significant tissue injury. Prior studies show that the use of low-pressure pneumoperitoneum (PNP) during laparoscopic surgery reduced postoperative pain scores, cumulative opioid consumption and improved bowel function recovery. Deep neuromuscular blockade (NMB) as compared to moderate NMB decreases the amount of intra-abdominal pressure required to achieve similar surgical conditions and enables the use of low-pressure PNP without compromising the quality of the surgical field and patient safety. Therefore, the use of deep NMB with low-pressure PNP could be a significant addition to the conventional Enhanced Recovery After Surgery (ERAS) protocols.

Objective: to establish the relationship between the use of low pressure pneumoperitoneum with deep neuromuscular blockade and the early quality of recovery after laparoscopic colorectal surgery.

Study design: a multi-center, blinded, randomized controlled clinical trial.

Study population: adult individuals scheduled for laparoscopic colorectal surgery with a primary colonic anastomosis.

Intervention: participants will be randomly assigned in a 1:1 fashion to either the experimental group (group A): low pressure PNP (8 mmHg) with deep NMB (PTC 1-2) or the control group (group B): normal pressure PNP (12 mmHg) with moderate NMB (TOF count 1-2).

Primary endpoint: Quality of recovery score (QoR-40) 24 hours after surgery.

Secondary endpoints: QoR-40 score (day 3 and 7 after surgery), McGill pain- and RAND-36 score (1 day before and 3 months after surgery), pain scores, PONV, analgesia use, length of hospital stay, postoperative complications, surgical conditions and time to reach discharge criteria.

Study Type

Interventional

Enrollment (Actual)

178

Phase

  • Phase 4

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Groningen, Netherlands
        • Martini general hospital
      • Veldhoven, Netherlands
        • Máxima Medisch Centrum
    • Gelderland
      • Nijmegen, Gelderland, Netherlands, 6532SZ
        • Canisius Wilhelmina Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

16 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Scheduled for laparoscopic colorectal surgery with a primary anastomosis
  • Obtained informed consent
  • Age over 18 years

Exclusion Criteria:

  • Insufficient control of the Dutch language to read the patient information and to fill out the questionnaires
  • Primary colostomy
  • Neo-adjuvant chemotherapy
  • Chronic use of analgesics or psychotropic drugs
  • Use of NSAIDs shorter than 5 days before surgery
  • Known or suspected allergy to rocuronium of sugammadex
  • Neuromuscular disease
  • Indication for rapid sequence induction
  • Severe liver- or renal disease (creatinine clearance <30ml/min)
  • BMI >35 kg/m²
  • Deficiency of vitamin K dependent clotting factors or coagulopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Low pressure PNP, deep NMB
Low pressure pneumoperitoneum of 8 mmHg with deep neuromuscular block (post tetanic count of 1-2) reached by titration with continuous infusion of Rocuronium bromide.
Lowering intra-abdominal pressure during laparoscopic surgery
Other Names:
  • Low intra-abdominal pressure
Deep (PTC 1-2) versus moderate (Tof count 1-2) neuromuscular block
Other Names:
  • Deep muscle relaxation
Active Comparator: Normal pressure PNP, moderate NMB
Normal pressure pneumoperitoneum of 12 mmHg with moderate neuromuscular block (TOF count of 1-2) reached by titration with bolus or continuous infusion of a low dose of Rocuronium bromide.
Deep (PTC 1-2) versus moderate (Tof count 1-2) neuromuscular block
Other Names:
  • Deep muscle relaxation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total score on the Quality of Recovery-40 questionnaire
Time Frame: 24 hours after surgery
The QoR-40 is a validated assessment tool for measuring a patient's self-assessed quality of recovery after surgery. It consists of 40 questions measuring 5 dimensions: patient support, comfort, emotions, physical independence and pain. Each item is rated on a scale of 1 to 5, giving a minimal score of 40 and a maximum score of 200.
24 hours after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total score on the Quality of Recovery-40 questionnaire
Time Frame: Day 3 and day 7 after surgery
The QoR-40 is a validated assessment tool for measuring a patient's self-assessed quality of recovery after surgery. It consists of 40 questions measuring 5 dimensions: patient support, comfort, emotions, physical independence and pain. Each item is rated on a scale of 1 to 5, giving a minimal score of 40 and a maximum score of 200.
Day 3 and day 7 after surgery
McGill pain Questionnaire
Time Frame: Upon admission and 3 months after surgery
Validated questionnaire for the assessment of quality and intensity of pain
Upon admission and 3 months after surgery
RAND-36 general health questionnaire
Time Frame: Upon admission and 3 months after surgery
Validated patient-reported survey of health
Upon admission and 3 months after surgery
Pain scores
Time Frame: 1, 8, 24, and 72 hours after surgery
Pain at rest and pain upon movement (NRS 0-10), is pain acceptable yes or no, referred shoulder pain yes or no?
1, 8, 24, and 72 hours after surgery
Post-operative nausea and vomiting (PONV)
Time Frame: 1, 8, 24 and 72 hours after surgery
NRS 0-10
1, 8, 24 and 72 hours after surgery
Cumulative use of analgesics and anti-emetics
Time Frame: 1, 8, 24 and 72 hours after surgery
Total dose of opiates, other analgesics and anti-emetic drugs
1, 8, 24 and 72 hours after surgery
Length of hospital stay
Time Frame: From date of admission until date of discharge from the hospital (usually several days), assessed up to 3 months.
Total number of days from admission to discharge after surgery (not including readmission)
From date of admission until date of discharge from the hospital (usually several days), assessed up to 3 months.
Surgical conditions
Time Frame: Intraoperative: after introduction of the trocars and every 15 minutes until the end of the pneumoperitoneum.
Rating of the surgical conditions with the Leiden Surgical Rating Scale (L-SRS). The L-SRS is scored by the surgeon and ranges from 1-5 for quality of the surgical field. A score of 5 means optimal conditions: a wide laparoscopic field with no patient movements or muscle contractions, 1 means extremely poor conditions: the surgeon is unable to obtain a visible laparoscopic field because of inadequate muscle relaxation.
Intraoperative: after introduction of the trocars and every 15 minutes until the end of the pneumoperitoneum.
Intraoperative complications
Time Frame: During surgery
Complications during surgery graded according to the Clavien-Dindo classification
During surgery
Postoperative complications
Time Frame: Up to 3 months after surgery
Postoperative complications
Up to 3 months after surgery
Time to reach discharge criteria
Time Frame: From date of surgery until date of actual discharge from the hospital (usually several days), assessed up to 3 months.
Number of days to reach the following criteria after surgery: adequate pain control with oral medication, passage of flatus or defecation, intake of solid food tolerated, patient is mobilized and independent and patient accepts discharge.
From date of surgery until date of actual discharge from the hospital (usually several days), assessed up to 3 months.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Michiel C Warlé, MD, PhD, Radboud University Medical Center
  • Principal Investigator: Kim I Albers, MD, Radboud University Medical Center

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 24, 2018

Primary Completion (Actual)

March 3, 2021

Study Completion (Actual)

June 3, 2021

Study Registration Dates

First Submitted

June 18, 2018

First Submitted That Met QC Criteria

July 30, 2018

First Posted (Actual)

August 1, 2018

Study Record Updates

Last Update Posted (Actual)

October 28, 2021

Last Update Submitted That Met QC Criteria

October 27, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pneumoperitoneum

Clinical Trials on Low pressure pneumoperitoneum

3
Subscribe